- Ripple ETFs face delays due to SEC concerns.
- SEC cites market manipulation, investor protection issues.
- Applications from Franklin Templeton, REX Osprey affected.
Ripple ETFs, including those from Franklin Templeton and REX Osprey, continue facing postponements by the SEC due to regulatory scrutiny, especially concerning market manipulation and investor protection concerns.
These delays hinder XRP’s broader market access, creating price fluctuations while highlighting regulatory differences with approved BTC and ETH ETFs, thus affecting institutional investment dynamics.
Ripple (XRP) spot ETF applications in the U.S. continue to confront postponements attributed to SEC regulatory scrutiny. Prominent applicants include Franklin Templeton and REX Osprey, both facing delays amid unresolved market manipulation concerns.
Franklin Templeton, a financial giant, submitted its application in February 2025. Recent comments highlight structural differences in XRP ETFs, with James Seyffart noting they are RICs. This fundamentally contrasts BTC and ETH ETFs.
XRP’s price has surged by 30% since June 2025, stimulated by ETF speculation. Franklin Templeton and REX Osprey’s challenges may impact institutional access and market liquidity in the near term.
Ongoing SEC concerns stall growth of XRP ETFs, with decisions extended by up to 60 days. Differences in structure, like the RIC format, complicate pathways compared to BTC and ETH ETFs.
These regulatory challenges echo past obstacles faced by BTC and ETH ETFs. Historical data shows SEC cautiousness with crypto ETFs, particularly due to market protection and manipulation issues.
The future of XRP ETFs may hinge on compliance with SEC standards, reflecting persistent regulatory uncertainties. Continued evaluation affects market trust and potential investor interest.
